Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_assertion type Assertion NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_head.
- NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_assertion description "[ABL mutations are common in Chinese imatinib-resistant CML patients and are associated with clinical resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_provenance.
- NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_assertion evidence source_evidence_literature NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_provenance.
- NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_assertion SIO_000772 20697894 NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_provenance.
- NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_assertion wasDerivedFrom befree-20140225 NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_provenance.
- NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_assertion wasGeneratedBy ECO_0000203 NP559796.RAL6qVE3_TaEPZSVFaJaauBNI3Svsiw9Z6Z8iGWaj5EWQ130_provenance.